{
    "eid": "2-s2.0-85097310680",
    "title": "Thrombolytic therapy in acute venous thromboembolism",
    "cover-date": "2020-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Thita Chiasakul",
        "Kenneth A. Bauer"
    ],
    "citedby-count": 2,
    "ref-count": 40,
    "ref-list": [
        "Pulmonary embolism hospitalization, readmission, and mortality rates in US older adults, 1999-2015",
        "National trends in hospitalizations for venous thromboembolism",
        "American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association [published corrections appear in Circulation. 2012;126(7):e104 and Circulation. 2012; 125(11):e495]",
        "2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)",
        "Massive pulmonary embolism",
        "Meta-analysis of prevalence and short-term prognosis of hemodynamically unstable patients with symptomatic acute pulmonary embolism",
        "Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial",
        "Contemporary management and outcomes of patients with massive and submassive pulmonary embolism",
        "Pulmonary embolism severity assessment and prognostication",
        "Predictive value of computed tomography in acute pulmonary embolism: systematic review and metaanalysis",
        "Prognostic value of troponins in acute nonmassive pulmonary embolism: a meta-analysis",
        "Fibrinolysis for patients with intermediate-risk pulmonary embolism",
        "Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism",
        "Thrombolytic therapy for pulmonary embolism",
        "MOPETT\u201d Investigators. Moderate pulmonary embolism treated with thrombolysis (from the \u201cMOPETT\u201d trial)",
        "Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial",
        "Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis",
        "Half-dose versus full-dose alteplase for treatment of pulmonary embolism",
        "A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism",
        "A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism",
        "Utilization of catheter-directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter-directed thrombolysis",
        "Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism",
        "A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study",
        "Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT): initial results from a prospective multicenter registry",
        "A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: the OPTALYSE PE trial",
        "A prospective, single-arm, multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism: the FLARE study",
        "Catheter-directed aspiration thrombectomy and low-dose thrombolysis for patients with acute unstable pulmonary embolism: prospective outcomes from a PE registry",
        "The implementation of a pulmonary embolism response team in the management of intermediate- or high-risk pulmonary embolism",
        "The impact of a pulmonary embolism response team on the efficiency of patient care in the emergency department",
        "Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis [published correction appears in J Thromb Thrombolysis. 2019;47(1):41]",
        "Impact of multidisciplinary pulmonary embolism response team availability on management and outcomes",
        "Changes in care for acute pulmonary embolism through a multidisciplinary pulmonary embolism response team [published online ahead of print 19 May 2020]",
        "How I treat the postthrombotic syndrome",
        "Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis",
        "Development and validation of a practical two-step prediction model and clinical risk score for post-thrombotic syndrome",
        "Derivation and validation of a prediction model for risk stratification of post-thrombotic syndrome in elderly patients with a first deep vein thrombosis",
        "Thrombolysis for acute deep vein thrombosis",
        "Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial",
        "Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis",
        "Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60002746",
            "affilname": "Harvard Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}